S-Ketamine’s Effect Changes the Cortical Electrophysiological Activity Related to Semantic Affective Dimension of Pain: A Placebo- Controlled Study in Healthy Male Individuals

BackgroundPrevious studies using the electroencephalogram (EEG) technique pointed out that ketamine decreases the amplitude of cortical electrophysiological signal during cognitive tasks, although its effects on the perception and emotional-valence judgment of stimuli are still unknown.ObjectiveWe e...

Full description

Bibliographic Details
Main Authors: André Schwertner, Maxciel Zortea, Felipe Vasconcelos Torres, Leticia Ramalho, Camila Fernanda da Silveira Alves, Guilherme Lannig, Iraci L. S. Torres, Felipe Fregni, Gustavo Gauer, Wolnei Caumo
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-09-01
Series:Frontiers in Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fnins.2019.00959/full
id doaj-4b52203212284cb990d4b3d7ba9fcec9
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author André Schwertner
André Schwertner
Maxciel Zortea
Maxciel Zortea
Felipe Vasconcelos Torres
Felipe Vasconcelos Torres
Leticia Ramalho
Leticia Ramalho
Camila Fernanda da Silveira Alves
Camila Fernanda da Silveira Alves
Guilherme Lannig
Iraci L. S. Torres
Iraci L. S. Torres
Felipe Fregni
Gustavo Gauer
Wolnei Caumo
Wolnei Caumo
spellingShingle André Schwertner
André Schwertner
Maxciel Zortea
Maxciel Zortea
Felipe Vasconcelos Torres
Felipe Vasconcelos Torres
Leticia Ramalho
Leticia Ramalho
Camila Fernanda da Silveira Alves
Camila Fernanda da Silveira Alves
Guilherme Lannig
Iraci L. S. Torres
Iraci L. S. Torres
Felipe Fregni
Gustavo Gauer
Wolnei Caumo
Wolnei Caumo
S-Ketamine’s Effect Changes the Cortical Electrophysiological Activity Related to Semantic Affective Dimension of Pain: A Placebo- Controlled Study in Healthy Male Individuals
Frontiers in Neuroscience
ERPs
ketamine
P300
pain
oddball
author_facet André Schwertner
André Schwertner
Maxciel Zortea
Maxciel Zortea
Felipe Vasconcelos Torres
Felipe Vasconcelos Torres
Leticia Ramalho
Leticia Ramalho
Camila Fernanda da Silveira Alves
Camila Fernanda da Silveira Alves
Guilherme Lannig
Iraci L. S. Torres
Iraci L. S. Torres
Felipe Fregni
Gustavo Gauer
Wolnei Caumo
Wolnei Caumo
author_sort André Schwertner
title S-Ketamine’s Effect Changes the Cortical Electrophysiological Activity Related to Semantic Affective Dimension of Pain: A Placebo- Controlled Study in Healthy Male Individuals
title_short S-Ketamine’s Effect Changes the Cortical Electrophysiological Activity Related to Semantic Affective Dimension of Pain: A Placebo- Controlled Study in Healthy Male Individuals
title_full S-Ketamine’s Effect Changes the Cortical Electrophysiological Activity Related to Semantic Affective Dimension of Pain: A Placebo- Controlled Study in Healthy Male Individuals
title_fullStr S-Ketamine’s Effect Changes the Cortical Electrophysiological Activity Related to Semantic Affective Dimension of Pain: A Placebo- Controlled Study in Healthy Male Individuals
title_full_unstemmed S-Ketamine’s Effect Changes the Cortical Electrophysiological Activity Related to Semantic Affective Dimension of Pain: A Placebo- Controlled Study in Healthy Male Individuals
title_sort s-ketamine’s effect changes the cortical electrophysiological activity related to semantic affective dimension of pain: a placebo- controlled study in healthy male individuals
publisher Frontiers Media S.A.
series Frontiers in Neuroscience
issn 1662-453X
publishDate 2019-09-01
description BackgroundPrevious studies using the electroencephalogram (EEG) technique pointed out that ketamine decreases the amplitude of cortical electrophysiological signal during cognitive tasks, although its effects on the perception and emotional-valence judgment of stimuli are still unknown.ObjectiveWe evaluated the effect of S-ketamine on affective dimension of pain using EEG and behavioral measures. The hypothesis was that S-ketamine would be more effective than placebo, both within and between groups, to attenuate the EEG signal elicited by target and non-target words.MethodsThis double-blind parallel placebo-controlled study enrolled 24 healthy male volunteers between 19 and 40 years old. They were randomized to receive intravenous S-ketamine (n = 12) at a plasmatic concentration of 60 ng/ml or placebo (n = 12). Participants completed a computerized oddball paradigm containing written words semantically related to pain (targets), and non-pain related words (standard). The volunteers had to classify the words either as “positive,” “negative” or “neutral” (emotional valence judgment). The paradigm consisted in 6 blocks of 50 words each with a fixed 4:1 target/non-target rate presented in a single run. Infusion started during the interval between the 3rd and 4th blocks, for both groups. EEG signal was registered using four channels (Fz, Pz, Pz, and Oz, according to the 10–20 EEG system) with a linked-earlobe reference. The area under the curve (AUC) of the N200 (interval of 100–200 ms) and P300 (300–500 ms) components of event-related potentials (ERPs) was measured for each channel.ResultsS-ketamine produced substantial difference (delta) in the AUC of grand average ERP components N200 (P = 0.05) and P300 (P = 0.02) at Pz during infusion period when compared to placebo infusion for both targets and non-targets. S-ketamine was also associated with a decrease in the amount of pain-related words judged as negative from before to after infusion [mean = 0.83 (SD = 0.09) vs. mean = 0.73 (SD = 0.11), respectively; P = 0.04].ConclusionOur findings suggest that S-ketamine actively changed the semantic processing of written words. There was an increase in electrophysiological response for pain-related stimuli and a decrease for standard stimuli, as evidenced by the increased delta of AUCs. Behaviorally, S-ketamine seems to have produced an emotional and discrimination blunting effect for pain-related words.Clinical Trial Registrationwww.ClinicalTrials.gov, identifier NCT03915938.
topic ERPs
ketamine
P300
pain
oddball
url https://www.frontiersin.org/article/10.3389/fnins.2019.00959/full
work_keys_str_mv AT andreschwertner sketamineseffectchangesthecorticalelectrophysiologicalactivityrelatedtosemanticaffectivedimensionofpainaplacebocontrolledstudyinhealthymaleindividuals
AT andreschwertner sketamineseffectchangesthecorticalelectrophysiologicalactivityrelatedtosemanticaffectivedimensionofpainaplacebocontrolledstudyinhealthymaleindividuals
AT maxcielzortea sketamineseffectchangesthecorticalelectrophysiologicalactivityrelatedtosemanticaffectivedimensionofpainaplacebocontrolledstudyinhealthymaleindividuals
AT maxcielzortea sketamineseffectchangesthecorticalelectrophysiologicalactivityrelatedtosemanticaffectivedimensionofpainaplacebocontrolledstudyinhealthymaleindividuals
AT felipevasconcelostorres sketamineseffectchangesthecorticalelectrophysiologicalactivityrelatedtosemanticaffectivedimensionofpainaplacebocontrolledstudyinhealthymaleindividuals
AT felipevasconcelostorres sketamineseffectchangesthecorticalelectrophysiologicalactivityrelatedtosemanticaffectivedimensionofpainaplacebocontrolledstudyinhealthymaleindividuals
AT leticiaramalho sketamineseffectchangesthecorticalelectrophysiologicalactivityrelatedtosemanticaffectivedimensionofpainaplacebocontrolledstudyinhealthymaleindividuals
AT leticiaramalho sketamineseffectchangesthecorticalelectrophysiologicalactivityrelatedtosemanticaffectivedimensionofpainaplacebocontrolledstudyinhealthymaleindividuals
AT camilafernandadasilveiraalves sketamineseffectchangesthecorticalelectrophysiologicalactivityrelatedtosemanticaffectivedimensionofpainaplacebocontrolledstudyinhealthymaleindividuals
AT camilafernandadasilveiraalves sketamineseffectchangesthecorticalelectrophysiologicalactivityrelatedtosemanticaffectivedimensionofpainaplacebocontrolledstudyinhealthymaleindividuals
AT guilhermelannig sketamineseffectchangesthecorticalelectrophysiologicalactivityrelatedtosemanticaffectivedimensionofpainaplacebocontrolledstudyinhealthymaleindividuals
AT iracilstorres sketamineseffectchangesthecorticalelectrophysiologicalactivityrelatedtosemanticaffectivedimensionofpainaplacebocontrolledstudyinhealthymaleindividuals
AT iracilstorres sketamineseffectchangesthecorticalelectrophysiologicalactivityrelatedtosemanticaffectivedimensionofpainaplacebocontrolledstudyinhealthymaleindividuals
AT felipefregni sketamineseffectchangesthecorticalelectrophysiologicalactivityrelatedtosemanticaffectivedimensionofpainaplacebocontrolledstudyinhealthymaleindividuals
AT gustavogauer sketamineseffectchangesthecorticalelectrophysiologicalactivityrelatedtosemanticaffectivedimensionofpainaplacebocontrolledstudyinhealthymaleindividuals
AT wolneicaumo sketamineseffectchangesthecorticalelectrophysiologicalactivityrelatedtosemanticaffectivedimensionofpainaplacebocontrolledstudyinhealthymaleindividuals
AT wolneicaumo sketamineseffectchangesthecorticalelectrophysiologicalactivityrelatedtosemanticaffectivedimensionofpainaplacebocontrolledstudyinhealthymaleindividuals
_version_ 1725106787876601856
spelling doaj-4b52203212284cb990d4b3d7ba9fcec92020-11-25T01:27:08ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2019-09-011310.3389/fnins.2019.00959474577S-Ketamine’s Effect Changes the Cortical Electrophysiological Activity Related to Semantic Affective Dimension of Pain: A Placebo- Controlled Study in Healthy Male IndividualsAndré Schwertner0André Schwertner1Maxciel Zortea2Maxciel Zortea3Felipe Vasconcelos Torres4Felipe Vasconcelos Torres5Leticia Ramalho6Leticia Ramalho7Camila Fernanda da Silveira Alves8Camila Fernanda da Silveira Alves9Guilherme Lannig10Iraci L. S. Torres11Iraci L. S. Torres12Felipe Fregni13Gustavo Gauer14Wolnei Caumo15Wolnei Caumo16Post-graduation Program in Medicine: Medical Sciences, Federal University of Rio Grande do Sul, Porto Alegre, BrazilLaboratory of Pain and Neuromodulation, Clinical Hospital of Porto Alegre, Porto Alegre, BrazilPost-graduation Program in Medicine: Medical Sciences, Federal University of Rio Grande do Sul, Porto Alegre, BrazilLaboratory of Pain and Neuromodulation, Clinical Hospital of Porto Alegre, Porto Alegre, BrazilPost-graduation Program in Medicine: Medical Sciences, Federal University of Rio Grande do Sul, Porto Alegre, BrazilLaboratory of Pain and Neuromodulation, Clinical Hospital of Porto Alegre, Porto Alegre, BrazilPost-graduation Program in Medicine: Medical Sciences, Federal University of Rio Grande do Sul, Porto Alegre, BrazilLaboratory of Pain and Neuromodulation, Clinical Hospital of Porto Alegre, Porto Alegre, BrazilPost-graduation Program in Medicine: Medical Sciences, Federal University of Rio Grande do Sul, Porto Alegre, BrazilLaboratory of Pain and Neuromodulation, Clinical Hospital of Porto Alegre, Porto Alegre, BrazilClinical Research Center, Clinical Hospital of Porto Alegre, Porto Alegre, BrazilPost-graduation Program in Biological Sciences: Physiology, Federal University of Rio Grande do Sul, Porto Alegre, BrazilPharmacology of Pain and Neuromodulation: Pre-clinical Investigations, Federal University of Rio Grande do Sul, Porto Alegre, BrazilNeuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, MA, United StatesPost-graduation Program in Psychology, Federal University of Rio Grande do Sul, Porto Alegre, BrazilPost-graduation Program in Medicine: Medical Sciences, Federal University of Rio Grande do Sul, Porto Alegre, BrazilLaboratory of Pain and Neuromodulation, Clinical Hospital of Porto Alegre, Porto Alegre, BrazilBackgroundPrevious studies using the electroencephalogram (EEG) technique pointed out that ketamine decreases the amplitude of cortical electrophysiological signal during cognitive tasks, although its effects on the perception and emotional-valence judgment of stimuli are still unknown.ObjectiveWe evaluated the effect of S-ketamine on affective dimension of pain using EEG and behavioral measures. The hypothesis was that S-ketamine would be more effective than placebo, both within and between groups, to attenuate the EEG signal elicited by target and non-target words.MethodsThis double-blind parallel placebo-controlled study enrolled 24 healthy male volunteers between 19 and 40 years old. They were randomized to receive intravenous S-ketamine (n = 12) at a plasmatic concentration of 60 ng/ml or placebo (n = 12). Participants completed a computerized oddball paradigm containing written words semantically related to pain (targets), and non-pain related words (standard). The volunteers had to classify the words either as “positive,” “negative” or “neutral” (emotional valence judgment). The paradigm consisted in 6 blocks of 50 words each with a fixed 4:1 target/non-target rate presented in a single run. Infusion started during the interval between the 3rd and 4th blocks, for both groups. EEG signal was registered using four channels (Fz, Pz, Pz, and Oz, according to the 10–20 EEG system) with a linked-earlobe reference. The area under the curve (AUC) of the N200 (interval of 100–200 ms) and P300 (300–500 ms) components of event-related potentials (ERPs) was measured for each channel.ResultsS-ketamine produced substantial difference (delta) in the AUC of grand average ERP components N200 (P = 0.05) and P300 (P = 0.02) at Pz during infusion period when compared to placebo infusion for both targets and non-targets. S-ketamine was also associated with a decrease in the amount of pain-related words judged as negative from before to after infusion [mean = 0.83 (SD = 0.09) vs. mean = 0.73 (SD = 0.11), respectively; P = 0.04].ConclusionOur findings suggest that S-ketamine actively changed the semantic processing of written words. There was an increase in electrophysiological response for pain-related stimuli and a decrease for standard stimuli, as evidenced by the increased delta of AUCs. Behaviorally, S-ketamine seems to have produced an emotional and discrimination blunting effect for pain-related words.Clinical Trial Registrationwww.ClinicalTrials.gov, identifier NCT03915938.https://www.frontiersin.org/article/10.3389/fnins.2019.00959/fullERPsketamineP300painoddball